These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36045680)

  • 1. Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.
    Cheng YL; Chao CH; Lai YC; Hsieh KH; Wang JR; Wan SW; Huang HJ; Chuang YC; Chuang WJ; Yeh TM
    Front Immunol; 2022; 13():941923. PubMed ID: 36045680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2.
    Hunsawong T; Buddhari D; Rungrojcharoenkit K; Suthangkornkul R; Mongkolsirichaikul D; Lohachanakul J; Tayong K; Sirikajornpan K; Rodpradit P; Poolpanichupatam Y; Klungthong C; Utennam D; Kaewhiran S; Cotrone TS; Fernandez S; Jones AR
    Microbiol Spectr; 2022 Dec; 10(6):e0263922. PubMed ID: 36445096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2.
    Lai YC; Cheng YW; Chao CH; Chang YY; Chen CD; Tsai WJ; Wang S; Lin YS; Chang CP; Chuang WJ; Chen LY; Wang YR; Chang SY; Huang W; Wang JR; Tseng CK; Lin CK; Chuang YC; Yeh TM
    Front Immunol; 2022; 13():868724. PubMed ID: 35603169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian anti-NS1 IgY antibodies neutralize dengue virus infection and protect against lethal dengue virus challenge.
    O'Donnell KL; Espinosa DA; Puerta-Guardo H; Biering SB; Warnes CM; Schiltz J; Nilles ML; Li J; Harris E; Bradley DS
    Antiviral Res; 2020 Nov; 183():104923. PubMed ID: 32979401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?
    Scaggs Huang F
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Opposing Roles of SARS-CoV-2 RBD-Reactive Antibodies in Pre-Pandemic Plasma Samples From Elderly People in ACE2-Mediated Pseudovirus Infection.
    Sim KY; Ko GH; Bae SE; Choi KY; Lee JS; Kim BC; Lee KH; Song MR; Park SG
    Front Immunol; 2021; 12():813240. PubMed ID: 35087532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.
    Munoz-Jordan J; Cardona J; Beltrán M; Colón C; Schiffer J; Stewart-Clark E; Zellner B; Semenova V; Li Y; Jia LT; Maniatis P; Pawloski L; Adams L; Paz-Bailey G; Rivera-Amill V; Medina F
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(10):375-377. PubMed ID: 35271558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological testing for SARS-CoV-2 antibodies in clinical practice: A comparative diagnostic accuracy study.
    Horn MP; Jonsdottir HR; Brigger D; Damonti L; Suter-Riniker F; Endrich O; Froehlich TK; Fiedler M; Largiadèr CR; Marschall J; Weber B; Eggel A; Nagler M
    Allergy; 2022 Jul; 77(7):2090-2103. PubMed ID: 34986501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1.
    Wan SW; Lu YT; Huang CH; Lin CF; Anderson R; Liu HS; Yeh TM; Yen YT; Wu-Hsieh BA; Lin YS
    PLoS One; 2014; 9(3):e92495. PubMed ID: 24658118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Risk of Serological Cross-Reactivity between the Dengue Virus and SARS-CoV-2-IgG Antibodies Using Advanced Detection Assays.
    Shurrab FM; Al-Sadeq DW; Amanullah FH; Al-Absi ES; Qotba H; Yassine HM; Abu-Raddad LJ; Nasrallah GK
    Intervirology; 2022; 65(4):224-229. PubMed ID: 35134813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.
    Dutta D; Ghosh A; Dutta C; Sukla S; Biswas S
    J Med Virol; 2023 Feb; 95(2):e28557. PubMed ID: 36755367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses.
    Lustig Y; Keler S; Kolodny R; Ben-Tal N; Atias-Varon D; Shlush E; Gerlic M; Munitz A; Doolman R; Asraf K; Shlush LI; Vivante A
    Clin Infect Dis; 2021 Oct; 73(7):e2444-e2449. PubMed ID: 32797228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein.
    Huang HJ; Yang M; Chen HW; Wang S; Chang CP; Ho TS; Kao YS; Tien SM; Lin HH; Chang PC; Lai YC; Hsiao YP; Liu YL; Chao CH; Anderson R; Yeh TM; Lin YS; Wan SW
    Vaccine; 2022 Apr; 40(15):2299-2310. PubMed ID: 35287985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study.
    Schaffner A; Risch L; Aeschbacher S; Risch C; Weber MC; Thiel SL; Jüngert K; Pichler M; Grossmann K; Wohlwend N; Lung T; Hillmann D; Bigler S; Bodmer T; Imperiali M; Renz H; Kohler P; Vernazza P; Kahlert CR; Twerenbold R; Paprotny M; Conen D; Risch M
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33317059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Combination of N and S Antigens With IgA and IgG Measurement Strengthens the Accuracy of SARS-CoV-2 Serodiagnostics.
    Jalkanen P; Pasternack A; Maljanen S; Melén K; Kolehmainen P; Huttunen M; Lundberg R; Tripathi L; Khan H; Ritvos MA; Naves R; Haveri A; Österlund P; Kuivanen S; Jääskeläinen AJ; Kurkela S; Lappalainen M; Rantasärkkä K; Vuorinen T; Hytönen J; Waris M; Tauriainen S; Ritvos O; Kakkola L; Julkunen I
    J Infect Dis; 2021 Jul; 224(2):218-228. PubMed ID: 33905505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes.
    Gattinger P; Niespodziana K; Stiasny K; Sahanic S; Tulaeva I; Borochova K; Dorofeeva Y; Schlederer T; Sonnweber T; Hofer G; Kiss R; Kratzer B; Trapin D; Tauber PA; Rottal A; Körmöczi U; Feichter M; Weber M; Focke-Tejkl M; Löffler-Ragg J; Mühl B; Kropfmüller A; Keller W; Stolz F; Henning R; Tancevski I; Puchhammer-Stöckl E; Pickl WF; Valenta R
    Allergy; 2022 Jan; 77(1):230-242. PubMed ID: 34453317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation.
    Chuang YC; Lin J; Lin YS; Wang S; Yeh TM
    J Immunol; 2016 Feb; 196(3):1218-26. PubMed ID: 26712948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Puenpa J; Wanlapakorn N; Chirathaworn C; Sudhinaraset N; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Ayuthaya TPN; Brukesawan C; Intharasongkroh D; Chaiwanichsiri D; Issarasongkhram M; Kitphati R; Mungaomklang A; Thitithanyanont A; Nagavajara P; Poovorawan Y
    PLoS One; 2022; 17(4):e0267102. PubMed ID: 35446889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection.
    Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS
    J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.